Publications, comments, and interviews with Aspring Capital executives
Aspring Capital advised VEON on $2.1 bn deal to sell its Russian operations to local management
Aspring Capital named #1 Russian M&A Advisor
Aspring Capital appointed the exclusive financial advisor to VK Company regarding $400 mln of Convertible Bonds due in 2025
Aspring Capital acted as advisor of National Medical Network on its sale
Anna Aralova shared her perspective on decreasing volume of transactions with Western companies leaving Russia
Anton Fedotov comments on healthcare mergers
Anna Aralova comments on Yandex Parent leaving the Russian market
Alexey Kupriyanov comments on brokerage business prospects in Russia